Cited by 531Neuroinflammation and Neurodegeneration MechanismsSingle-cell and spatial transcriptomicsNeuroscience and Neuropharmacology Research

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Open access
Patani, Rickie, Hardingham, Giles E., Liddelow, Shane A.·2023·Nature Reviews Neurology

Abstract

Despite advances in uncovering the mechanisms that underlie neuroinflammation and neurodegenerative disease, therapies that prevent neuronal loss remain elusive. Targeting of disease-defining markers in conditions such as Alzheimer disease (amyloid-β and tau) or Parkinson disease (α-synuclein) has been met with limited success, suggesting that these proteins do not act in isolation but form part of a pathological network. This network could involve phenotypic alteration of multiple cell types in the CNS, including astrocytes, which have a major neurosupportive, homeostatic role in the healthy CNS but adopt reactive states under acute or chronic adverse conditions. Transcriptomic studies in human patients and disease models have revealed the co-existence of many putative reactive sub-states of astrocytes. Inter-disease and even intra-disease heterogeneity of reactive astrocytic sub-states are well established, but the extent to which specific sub-states are shared across different diseases is unclear. In this Review, we highlight how single-cell and single-nuclei RNA sequencing and other 'omics' technologies can enable the functional characterization of defined reactive astrocyte states in various pathological scenarios. We provide an integrated perspective, advocating cross-modal validation of key findings to define functionally important sub-states of astrocytes and their triggers as tractable therapeutic targets with cross-disease relevance.

Integrity signals

Registry

Crossref · 10.1038/s41582-023-00822-1

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Astrocyte and microglia iPSC models partially recapitulate the transcriptomes of their in vivo counterparts and may capture authentic neurodegenerative disease phenotypes.

    “Astrocyte and microglia iPSC models partially recapitulate the transcriptomes of their in vivo counterparts and may capture authentic neurodegenerative disease phenotypes [345,406,480,481,482,483,484].”

    From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [406]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Patani, R., Hardingham, G. E., & Liddelow, S. A.
Affiliations
  • The Francis Crick Institute (GB)
  • UK Dementia Research Institute (GB)
  • NYU Langone Health (US)
Corresponding author
Liddelow, Shane A.
Venue
Nature Reviews Neurology
Published
2023-06-12
Volume
19
Issue
7
Pages
395-409
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W4380367860
Cited by
531
References
46
Citations by year
2026: 140 · 2025: 202 · 2024: 162 · 2023: 26 · 2021: 1
FWCI
14.01
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Medical Research Council (MR/S006591/1)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
reactive astrocytes, astrocyte heterogeneity, neuroinflammation, neurodegeneration, Alzheimer's disease, Parkinson's disease, amyloid-beta, tau protein, alpha-synuclein, single-cell RNA sequencing, single-nucleus RNA sequencing, therapeutic target
MeSH terms
Neuroinflammatory Diseases, Alzheimer Disease, Astrocytes, Humans, Parkinson Disease, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review